Maravai Lifesciences Holdings (MRVI) Income towards Parent Company (2020 - 2025)
Historic Income towards Parent Company for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$45.1 million.
- Maravai Lifesciences Holdings' Income towards Parent Company rose 7387.32% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 3391.36%. This contributed to the annual value of -$259.6 million for FY2024, which is 8762.2% down from last year.
- As of Q3 2025, Maravai Lifesciences Holdings' Income towards Parent Company stood at -$45.1 million, which was up 7387.32% from -$69.8 million recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' Income towards Parent Company registered a high of $156.7 million during Q2 2022, and its lowest value of -$172.5 million during Q3 2024.
- Over the past 5 years, Maravai Lifesciences Holdings' median Income towards Parent Company value was -$11.9 million (recorded in 2023), while the average stood at $20.7 million.
- In the last 5 years, Maravai Lifesciences Holdings' Income towards Parent Company surged by 922711.51% in 2021 and then crashed by 158249.26% in 2024.
- Over the past 5 years, Maravai Lifesciences Holdings' Income towards Parent Company (Quarter) stood at $127.1 million in 2021, then plummeted by 31.22% to $87.4 million in 2022, then tumbled by 225.8% to -$110.0 million in 2023, then skyrocketed by 58.11% to -$46.1 million in 2024, then increased by 2.19% to -$45.1 million in 2025.
- Its Income towards Parent Company was -$45.1 million in Q3 2025, compared to -$69.8 million in Q2 2025 and -$52.9 million in Q1 2025.